Trial intelligence / Profile preview

High-Dose Quinapril vs Low-Dose Quinapril Plus Amlodipine in Hypertension

NCT00313547Phase 4Terminated

Sponsor
Montréal Heart Institute
Start
Apr 2006
Primary completion
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in hypertension (HTN) comparing Quinapril 40 mg with Quinapril 10 mg + Amlodipine 5 mg (2 arms). Primary endpoint: Heart rate variability at 24 hours. Started Apr 2006; status: terminated.

02

Drugs

quinaprilamlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00313547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00313547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call